Prostate cancer decisions — 2024

The Veteran's PTSD and MDD are related to an in-service event, leading to their service connection. The claims for prostate cancer and bladder cancer due to toxic exposures are remanded.

The Board dismissed the appeal as it was not ripe for review because the proposed rating reduction and discontinuance of SMC were only proposals, not final decisions.

The Board has remanded the Veteran's claims for service connection for prostate cancer and rectal cancer due to a pre-decisional duty to assist error. The Veteran is requested to undergo VA examinations to determine if his cancers are at least as likely as not caused by exposure to contaminated waters at Camp Lejeune.

Service connection for prostate cancer is granted on a presumptive basis due to herbicide exposure in Vietnam. The claim for bilateral pes planus is remanded and will be readjudicated based on new evidence received since the last denial.

The Board denied service connection for prostate cancer, lymph node cancer as secondary to prostate cancer, and depression as secondary to prostate cancer due to lack of evidence linking these conditions to the Veteran's service.

The Veteran is granted special monthly compensation (SMC) at the housebound rate effective February 6, 2014. His service-connected PTSD and other disabilities meet the criteria for SMC.

The Veteran's prostate cancer residuals are rated at 40 percent, effective April 1, 2017. The Board has remanded the case for further development regarding his psychiatric disability and TDIU.

The Board denied service connection for prostate cancer, heart disease (including atrial fibrillation and ischemic heart disease), and erectile dysfunction. The Veteran was not shown to have been exposed to herbicide agents during his service aboard the U.S.S. INTREPID.

The Board has decided to remand the case due to insufficient information about the Veteran's cause of death and the need for additional medical opinions. The appellant is asked to provide any relevant treatment records, including those from hospice care, prostate cancer, PTSD, and Alzheimer's disease.

Your claim for service connection for prostate cancer has been granted, but the appeal is dismissed because your case no longer involves any unresolved issues.

The Board has granted service connection for prostate cancer, hypertension, and type II diabetes mellitus based on the Veteran's exposure to hazardous materials during his military service at Fort McClellan.

The Board has granted service connection for prostate cancer due to herbicide exposure and for erectile dysfunction as secondary to the service-connected prostate cancer.

The Veteran's prostate cancer, left eye nonproliferative diabetic retinopathy, left lower extremity and right lower extremity diabetic peripheral neuropathy, and coronary artery disease (status post NSTEMI) have been granted initial evaluations. Effective dates for these determinations are also established.

The Board denied DIC benefits due to the Veteran's death not being caused by VA carelessness, negligence, or similar fault. The Appellant argued that VA was negligent in failing to diagnose liver cancer earlier, but the VA medical opinion concluded that VA did not fail to exercise proper care.

The Board has determined that the reduction in evaluation of prostate cancer residuals from 100 percent to 40 percent, effective September 1, 2023, was proper and restoration of a 100 percent disability rating is not warranted.

The Board has remanded the claims for service connection for prostate cancer and bilateral wrist disability due to outstanding development. The Veteran's prostate cancer is not shown to have had its onset in service, and there is no evidence of a relationship between his current condition and service. For the bilateral wrist disability, the claim was also denied as there is no evidence of a relationship with service.

The Board has remanded the claims for Parkinson's disease, prostate cancer, erectile dysfunction secondary to prostate cancer, and urinary incontinence secondary to prostate cancer due to a need for further development. Specifically, a VA examination is required to determine if these conditions are related to the Veteran's service exposure to toxic substances based on his military deployment and MOS as a munitions systems journeyman.

The Board has determined that the Veteran's prostate cancer is presumed to be related to herbicide exposure during his service aboard the USS Kitty Hawk, and thus grants the claim for service connection.

The Board denied an effective date prior to December 28, 2020 for the grant of service connection for prostate cancer as there was no pending claim or diagnosis before that date.

The Veteran's Parkinson's disease with speech changes has been granted a 30 percent rating, and other service-connected conditions have also been rated. The appeal is denied for higher ratings.